Pure Global

Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome - Trial NCT06374420

Access comprehensive clinical trial information for NCT06374420 through Pure Global AI's free database. This phase not specified trial is sponsored by Mansoura University and is currently Completed. The study focuses on COVID-19. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06374420
Completed
Trial Details
ClinicalTrials.gov โ€ข NCT06374420
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome

Study Focus

COVID-19

Observational

Sponsor & Location

Mansoura University

Mansoura, Egypt

Timeline & Enrollment

N/A

Sep 01, 2021

Apr 01, 2024

100 participants

Primary Outcome

investigating pulmonary sequelae of covid-19.,investigating pulmonary sequelae of covid-19.

Summary

The aim of this work is to estimate the frequency of small airway disease and/or the
 bronchial hyperreactivity in follow up of postacute covid survivors.

ICD-10 Classifications

COVID-19, virus identified
COVID-19, virus not identified
Coronavirus infection, unspecified site
Viral infection, unspecified
Rift Valley fever

Data Source

ClinicalTrials.gov

NCT06374420

Non-Device Trial